Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Tigapuluh tiga ekor sapi perah penderita mastitis subklinis dikelompokkan dalam grup A (10 ekor), grup B (12 ekor) dan grup C (11 ekor). Sapi diobati dengan homeopatika dalam bentuk kombinasi dan plasebo, pada minggu ke-4 dan 3 sebelum partus (a.p) dan setiap minggu selama 4 kali berturut-turut setelah partus (p.p).Grup A diobati dengan Coenzyme comp® (minggu ke-4 dan 3 a.p), Lachesis comp®dan Traumeel® (minggu ke-1 dan 2 p.p), Coenzyme comp® dan Carduus comp® (minggu ke-3 dan 4 p.p). Grup B diobati dengan Traumeel ® dan Mucosa comp® (minggu ke-4 dan 3 a.p), Lachesis comp® dan Traumeel® (minggu ke-1 dan 2 p.p), Coenzyme comp® dan Carduus comp® (minggu ke-3 dan 4 p.p). Grup C adalah plasebo. Kasus mastitis subklinis bagi grup A dan C sangat bervariasi sedangkan grup B memperlihatkan insidensi sebesar 33.3 % dan bertahan konstan sampai akhir pengamatan. Kenaikan jumlah sel somatik susu dari grup A dan B satu minggu setelah terapi terakhir selama 2 minggu (minggu ke-5 – 7 p.p) memperlihatkan adanya suatu respon yang nyata terhadap terapi homeopathy. Menjelang kelahiran terjadi peningkatan haptoglobin (Hp) bagi grup B 0.857 mg/ml dan grup A juga plasebo 1.438 mg/ml serta 1.422 mg/ml. Setelah partus sampai akhir pengamatan, grup B memperlihatkan penurunan Hp mencapai 0.074 mg/ml. Kadar Hp darah grup A menurun secara perlahan, kadar terendah dicapai 0.176 mg/ml. Pengamatan produksi susu selama 5 bulan (dari bulan ke-3 sampai ke-7) dalam masa laktasi normal menunjukkan adanya peningkatan 14.5% bagi grup B dan 4.98 % bagi grup A. (Med J Indones 2004; 13: 221-6)

---

A total of 33 dairy lactating cows suffering from subclinical mastitis were classified into group A (10 cows), group B (12 cows) and group C (11 cows). They were treated with the combination of homeopathic drugs and placebo, applied at the 4th and 3rd week antepartum (a.p), and continuing every week postpartum (p.p), for four times. Group A received Coenzyme comp® (in the 4th and 3rd week a.p), Lachesis comp® combined with Traumeel®(1st and 2nd week p.p) and Coenzyme comp® combined with Carduus comp® (3rd and 4th week p.p). Group B received Traumeel®+ Mucosa comp® (4th and 3rd week a.p), Lachesis comp®+ Traumeel® (1st and 2nd week p.p) and Coenzyme comp®+ Carduus comp® (3rd and 4th week p.p) and group C as a placebo. The incidence of subclinical mastitis in group A and C appeared irregular. In contrast, group B showed a constant percentage (33.3%). Group A and B showed significant response to the homeopathic drugs, expressed as an increasing of the somatic cell count value. At peripartal phase, haptoglobin increased in group B 0.80 mg/ml and group A as well as placebo 1.40 mg/ml. After calving, group B expressed a constant value (0.05 mg/ml), while group A and placebo rose significantly. The milk yield in normal lactation period (the 3rd - 7th month) increased significantly, with an increasing 14.1% for group B and 4.9% A respectively. (Med J Indones 2004; 13: 221-6)

Abstrak :
An illustrated reference guide, revised and updated, containing a photographic index of 150 remedies and the plant, animal or mineral ingredients from which they are made. The book includes easy-to-consult practical ailment charts which recommend remedies for a wide range of common aliments.

Abstrak :
David S. Riley’s interest in the history, methodology, and results of homeopathic drug provings came from his study of homeopathy at the Hahnemann College of Homeopathy in Albany, California. The 69 drug homeopathic drug provings published here are the result of his investigation of the research methods of homeopathic drug provings that form part of the basis for prescribing in homeopathy. In Dr. Hahnemann’s time the method by which the treatment profiles of homeopathic remedies were determined was called provings, after the original German word Prüfung, which means "test." Scientific research methods have evolved from the early days of homeopathy and Dr. Riley, in an attempt to improve transparency and reduce bias, has incorporated elements of contemporary research methods such as randomization, blinding, and formal good clinical practice guidelines (GCP) into homeopathic drug provings, while adhering to the general guidelines suggested by Dr. Hahnemann and used by homeopathic practitioners and researchers around the world.